Berotec N

Berotec N

fenoterol

Manufacturer:

Boehringer Ingelheim

Distributor:

DKSH
Concise Prescribing Info
Contents
Fenoterol HBr
Indications/Uses
Symptomatic treatment of acute asthma attacks; bronchial asthma & other conditions w/ reversible airway narrowing eg, chronic obstructive bronchitis. Prophylaxis of exercise-induced asthma.
Dosage/Direction for Use
Acute asthma episodes & other conditions w/ reversible airway narrowing 1 actuation. If breathing has not improved after 5 min, a 2nd actuation may be taken. Max: 8 actuations daily. Prophylaxis of exercise-induced asthma 1-2 actuations prior to exercise. Max: 8 actuations daily. Bronchial asthma & other conditions w/ reversible airways narrowing If repeated dosing is required, 1-2 puffs to be given each time. Max: 8 puffs daily.
Contraindications
Hypersensitivity. Hypertrophic obstructive cardiomyopathy, tachyarrhythmia.
Special Precautions
Discontinue if paradoxical bronchospasm occurs. Acute, rapidly worsening dyspnea. Insufficiently controlled DM, recent MI, severe organic heart or vascular disorders, hyperthyroidism, phaeochromocytoma. Hypokalaemia. Concomitant treatment w/ xanthine derivatives, glucocorticosteroids & diuretics & use w/ sympathomimetic & anticholinergic bronchodilators. May affect ability to drive & use machines. Pregnancy & lactation.
Adverse Reactions
Hypersensitivity; hypokalaemia; agitation, nervousness; tremor, headache, dizziness; myocardial ischaemia, arrhythmia, tachycardia, palpitations; paradoxical bronchospasm, cough, throat irritation; nausea, vomiting; hyperhidrosis, skin reaction eg, rash, pruritus, urticaria; muscle spasm, myalgia, muscular weakness; increased systolic BP, decreased diastolic BP.
Drug Interactions
Enhanced effects by β-adrenergics, anticholinergics & xanthine derivatives eg, theophylline. Increased β2-agonist induced hypokalaemia w/ corticosteroids & diuretics. Potentially serious reduction in bronchodilatation w/ β-blockers. Enhanced β-adrenergic agonists action w/ MAOIs or TCAs. Increased susceptibility to CV effects of β-agonists w/ halogenated hydrocarbon anaesth eg, halothane, trichloroethylene & enflurane.
ATC Classification
R03AC04 - fenoterol ; Belongs to the class of adrenergic inhalants, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.
Presentation/Packing
Form
Berotec N MDI 100 mcg/puff
Packing/Price
200 puff x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in